Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Sitagliptin and Vildagliptin on GLP-1 Feedback in T2D
NCT02749032Phase 1Completed
- Start
- Nov 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sitagliptin and vildagliptin in type 2 diabetes mellitus (T2DM) (6 arms). Primary endpoint: GLP-1 feedback inhibition. Started Nov 2011; status: completed.
02
Drugs
sitagliptinvildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02749032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02749032.